EGFR and ovarian cancer: The down regulation of GALNT14, which is up-regulated in ovarian cancer, inhibits the activity of mTOR pathway through O-glycosylation of EGFR, thereby inhibiting ferroptosis in ovarian cancer cells (Lee et al., 2020).